Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 420,400 | 310,900 | 171,200 | 396,100 | 334,100 |
| Marketable Securities | 516,500 | 210,500 | 279,300 | 0 | N/A |
| Receivables | 328,000 | 347,500 | 320,700 | 302,500 | 272,100 |
| Inventories | 308,900 | 281,000 | 261,300 | 203,600 | 165,900 |
| Income taxes - deferred | 33,400 | 43,400 | 43,900 | 32,300 | 48,300 |
| Other current assets | 71,800 | 57,000 | 57,100 | 62,700 | 35,100 |
| TOTAL | $1,725,800 | $1,291,900 | $1,168,500 | $1,032,600 | $889,200 |
| Non-Current Assets | |||||
| PPE Net | 421,600 | 373,300 | 304,300 | 269,800 | 252,000 |
| Investments And Advances | 21,900 | 21,100 | 21,800 | 25,000 | 22,300 |
| Intangibles | 418,900 | 451,700 | 416,700 | 382,300 | 401,900 |
| Other Non-Current Assets | 121,700 | 83,500 | 69,200 | 57,500 | 50,100 |
| TOTAL | $984,100 | $929,600 | $812,000 | $734,600 | $726,300 |
| Total Assets | $2,709,900 | $2,221,500 | $1,980,500 | $1,767,200 | $1,615,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 41,800 | N/A |
| Accounts payable and accrued liabilities | 48,400 | 74,700 | 85,000 | 47,600 | 51,100 |
| Accrued Expenses | 297,200 | 272,700 | 234,800 | 226,100 | 203,500 |
| TOTAL | $345,600 | $347,400 | $335,200 | $337,800 | $290,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 593,100 | 189,300 | 150,400 | N/A | 90,300 |
| aiOther Non-Current Liabilities | 226,800 | 205,500 | 157,000 | 121,200 | 76,800 |
| TOTAL | $819,900 | $394,800 | $307,400 | $121,200 | $167,100 |
| Total Liabilities | $1,165,500 | $742,200 | $642,600 | $459,000 | $457,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 643,443 | 684,604 | 689,883 | 689,104 | 678,707 |
| Common Shares | 126,000 | 124,200 | 120,000 | 117,000 | 76,100 |
| Retained earnings | 2,030,800 | 1,653,900 | 1,360,700 | 1,124,000 | 906,000 |
| Other shareholders' equity | -27,600 | -37,800 | -37,300 | -42,100 | -8,200 |
| TOTAL | $1,544,400 | $1,479,300 | $1,337,900 | $1,308,200 | $1,157,900 |
| Total Liabilities And Equity | $2,709,900 | $2,221,500 | $1,980,500 | $1,767,200 | $1,615,500 |